NASDAQ$DXCM

DexCom Inc · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

DexCom reported solid revenue growth but faced margin compression.

DexCom achieved 8.00% YoY revenue growth in Q4 2024, reaching $1,113,500,000. However, net income declined significantly by 40.80% YoY due to increased operating expenses and margin pressure.

  • Revenue increased by 8.00% YoY, reaching $1,113,500,000.
  • International revenue growth of 17.00% outpaced U.S. revenue growth of 4.00%.
  • Net income declined 40.80% YoY, mainly due to higher expenses and margin compression.
  • GAAP operating margin dropped 400 bps YoY to 17.00%.

Headline financials

Total Revenue

$1.11B

Previous: $1.03B+7.6%
EPS (adj)

$0.45

Previous: $0.50-10.0%
GAAP Operating Margin

17.0%

Previous: 21.0%-19.0%
Non-GAAP Operating Margin

18.8%

No prior period
GAAP Gross Profit Margin

58.9%

No prior period
Non-GAAP Gross Profit Margin

59.4%

No prior period
Adjusted EBITDA

$300M

No prior period
Net Income

$152M

Previous: $256M-40.8%
Operating Income

$189M

Previous: $217M-12.9%
Gross Profit

$654M

Previous: $657M-0.4%

Revenue & EPS history

DexCom · Revenue · Quarterly

$1.11B

Q4 2024+7.6%vs Q4 2023
Beat estimate in 11 of 15 quarters(73%)
ActualEstimate

Forward guidance

DexCom expects continued revenue growth in 2025, with strong international expansion and improving margins.

Tailwinds

  • Projected revenue growth of 14.00% to approximately $4,600,000,000.
  • Non-GAAP gross profit margin expected between 64.00% and 65.00%.
  • Non-GAAP operating margin projected at approximately 21.00%.
  • Adjusted EBITDA margin expected to reach 30.00%.
  • Expansion of reimbursement coverage in France for Dexcom ONE+ product.

Headwinds

  • Margin pressure persists despite projected improvements.
  • U.S. revenue growth remains relatively slow at 4.00% in Q4 2024.
  • Hardware revenue saw a significant decline of 49.00% YoY.
  • Increasing operating expenses continue to impact profitability.
  • Potential headwinds from foreign exchange fluctuations in international markets.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+1.6%

Avg return

Earnings day

+2.0%

Avg return

5 days after

+1.8%

Avg return

30 days after

56%

36 / 64 earnings

Positive

+31.1%

Q2 2018

Best reaction

-42.8%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+9.8%+1.4%+23.8%
Q4 2025+7.6%+11.9%-1.3%
Q3 2025+1.6%-13.1%-6.9%
Q1 2025+16.0%+18.6%+22.1%
Q4 2024+5.9%+6.6%-15.9%
Q3 2024+1.3%-0.3%+0.5%
Q2 2024-42.8%-37.7%-33.8%
Q1 2024-9.8%-7.6%-7.6%
Q4 2023-4.8%-7.6%+6.8%
Q3 2023+5.9%+5.3%+33.9%
Q2 2023+1.3%-6.6%-22.9%
Q1 2023-2.9%-5.5%-7.9%
Q4 2022+7.3%+7.9%-1.9%
Q3 2022+17.8%+16.0%+9.2%
Q2 2022-4.3%+2.9%-1.5%
Q1 2022-1.1%-4.3%-30.0%
Q4 2021-6.1%-6.8%-12.9%
Q3 2021+11.6%+14.5%+6.0%
Q2 2021+12.1%+13.3%+13.2%
Q1 2021-9.3%-12.8%-13.2%
Q4 2020+3.3%+1.2%-10.4%
Q3 2020-16.5%-23.5%-25.2%
Q2 2020+0.9%+2.9%+1.0%
Q1 2020+3.1%+1.9%+8.0%
Q4 2019+15.4%+20.3%-0.8%
Q3 2019+26.8%+33.9%+46.4%
Q2 2019-5.2%-9.1%+9.7%
Q1 2019-0.6%+0.9%+0.2%
Q4 2018-5.9%-4.1%-11.3%
Q3 2018+10.5%+14.2%-1.0%
Q2 2018+31.1%+28.1%+51.8%
Q1 2018+14.2%+16.6%+25.6%
Q4 2017-1.4%+6.6%+3.0%
Q3 2017+6.1%+11.1%+29.0%
Q2 2017+7.1%+6.8%+12.0%
Q1 2017-7.1%-4.3%-16.0%
Q4 2016+2.9%+1.6%+7.3%
Q3 2016-19.6%-20.9%-19.0%
Q2 2016-1.9%-1.5%-1.0%
Q1 2016-5.5%
Q4 2015+1.4%
Q3 2015-3.0%
Q2 2015+9.9%
Q1 2015-0.7%
Q4 2014+0.6%
Q3 2014+15.7%
Q2 2014+10.9%
Q1 2014-1.8%
Q4 2013-3.1%
Q3 2013+16.4%
Q2 2013+18.7%
Q1 2013+10.0%
Q4 2012+9.2%
Q3 2012-1.5%
Q2 2012+2.4%
Q1 2012+2.0%
Q4 2011-3.6%
Q3 2011-16.2%
Q2 2011-17.7%
Q1 2011-1.7%
Q4 2010+5.3%
Q3 2010-22.1%
Q2 2010+5.5%
Q1 2010-9.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro